---
title: "Antiverse: Antiverse develops AI-designed antibodies for challenging drug targets."
url: https://emrr.uz/antiverse
language: en
updated: 2026-11-20T06:01:51Z
source: emrr (https://emrr.uz)
---

# Antiverse

Antiverse develops AI-designed antibodies for challenging drug targets.

[antiverse.io](https://www.antiverse.io/)

- **Industry**: Biotech
- **Founded**: 2017
- **Team size**: 10-49 people
- **Based in**: Wales, United Kingdom

## Verified revenue: not connected yet

Is Antiverse yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

[Claim it if it’s yours](https://panel.emrr.uz/reserve/antiverse)

## About

Antiverse is a techbio company specializing in the design of antibodies for difficult drug targets such as GPCRs and ion channels. Using advanced machine learning and cell line engineering, the company develops new antibody therapeutics aimed at enabling innovative treatments for patients. Headquartered in Cardiff, Wales, United Kingdom, with an office in Boston, Massachusetts, Antiverse combines biotechnology and AI to accelerate the discovery of next-generation therapies and bring life-changing medicines to patients.

## Team

- **Murat Tunaboylu**, CEO & Co-founder (Founder)
- **Ben Holland**, Co-Founder & CTO (Founder)

## Audience

Followers on social networks

- [YouTube @antiversehq](https://www.youtube.com/@antiversehq): ≈55 subscribers (Public count, read by emrr from YouTube (rounded), 20 November 2026)
- [X @antiversehq](https://x.com/antiversehq)
- [LinkedIn antiverse](https://www.linkedin.com/company/antiverse/)

Profile data from Stanbase.

Updated 20 November 2026

[This page in Markdown](https://emrr.uz/antiverse.md)

[Get your verified page](https://emrr.uz/): Connect Stripe, the App Store or Google Play in two minutes and get a page like this one. emrr reads every figure itself, so investors don’t have to take your word for it. Free while MRR is under $1,000.
